Greater global harmonization of pharmacovigilance inspections will require a more diverse mix of regulators at the discussion table, according to the UK’s medicines regulator.
Greater global harmonization of pharmacovigilance inspections will require a more diverse mix of regulators at the discussion table, according to the UK’s medicines regulator.